Nachrichten zur Bristol-Myers Squibb Co. Aktie

GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy Exchange for Patient Advocates

ROCHESTER, N.Y. and PRINCETON, N.J. , May 12, 2020 /PRNewswire/ -- In light…

Is Bristol-Myers Squibb (BMY) Stock Undervalued Right Now-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Bristol Myers Squibb Offers bluebird bio a $200 Million Royalty Buyout

The pharma giant and the smaller biotech will keep working together on a couple of promising CAR-T cancer therapies....…

UPDATE 1-Bristol Myers to pay bluebird $200 mln for future royalties on cancer therapies

Bluebird bio Inc said on Monday Bristol Myers Squibb Co would give it a one-time payment of $200 million to buy out…

Bristol Myers to pay $200 mln to Bluebird for royalty obligations

Bluebird bio Inc said on Monday partner Bristol Myers Squibb Co would pay $200 million to buy out future royalty obligations on…

Bristol-Myers buys out of milestone and royalty commitment with bluebird for $200M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb: This Could Be The Next Quarter Trillion Dollar Company

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY

Novo Nordisk (NVO) and Bristol-Myers (BMY) announce Q1 results. Pfizer (PFE), Roche (RHHBY) and Lilly (LLY) provide update on their…

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb Co (BMY) Q1 2020 Earnings Call Transcript

BMY earnings call for the period ending March 31, 2020....…

Bristol-Myers Squibb Company 2020 Q1 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

3 Reasons Bristol Myers Squibbs Revenue Skyrocketed in Q1

The big drugmakers blockbuster cancer immunotherapy Opdivo wasnt one of them....…

Mid-Morning Market Update: Markets Open Higher; Bristol-Myers Squibb Tops Q1 Estimates

Following the market opening Thursday, the Dow traded up 1.19% to 23944.49 while the NASDAQ rose 1.11% to 8952.54. The…

Bristol-Myers Climbs After Strong Earnings, Upbeat Forecast

The company announced first-quarter earnings that beat Wall Street expectations and maintained its previous revenue guidance for 2020....…

Bristol-Myers Squibb dank Zukauf mit hohen Umsätzen aber auch hohen Verlusten

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Bristol-Myers Squibb (BMS) (Bristol-Myers Squibb) ist zum Jahresauftakt durch den Kauf des US-Biopharmaspezialisten Celgene,…

Bristol-Myers Squibb dank Zukauf mit hohen Umsätzen aber auch hohen Verlusten

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Bristol-Myers Squibb (BMS) ist zum Jahresauftakt durch den Kauf…

US-Pharmakonzern Bristol-Myers hält an Ergebniszielen fest

Um den gesamten Artikel unter de.reuters.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Tops Q1 Earnings and Revenue Estimates

Bristol-Myers (BMY) delivered earnings and revenue surprises of 16.22% and 8.62%, respectively, for the quarter ended March 2020. Do the…

US-Pharmakonzern Bristol-Myers hält an Ergebniszielen fest

New York (Reuters) - Der US-Pharmakonzern Bristol Myers Squibb hat im ersten Quartal besser als erwartet abgeschnitten und seine Ergebnisprognose…

Bristol-Myers Q1 Results Beat View; Cuts 2020 GAAP Profit Outlook

Biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reported a loss in the first quarter, compared to profit last year. The company…

Bristol-Myers Squibb affirms guidance, sees 20% earnings growth in 2021

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Bristol Myers sees 2020 earnings holding despite coronavirus pandemic

Bristol Myers Squibb Co on Thursday reported better-than-expected first-quarter results, and said it still expects 2020 earnings within its previously forecast range despite…

Bristol-Myers Squibbs stock gains 2% on strong EPS

Shares of Bristol-Myers Squibb gained 2.6% in premarket trading on Thursday after the drugmaker posted stronger-than-expected adjusted first-quarter earnings.…

Bristol Myers Beats Q1 Earnings Forecasts, Confirms 2020 Profit Guidance; Sees Near-Term COVID-19 Impact Peak

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers sees 2020 earnings holding despite coronavirus pandemic

Bristol Myers Squibb Co on Thursday reported better-than-expected first-quarter results, and said it still expects 2020 earnings within its previously forecast range despite…

Unemployment, Peloton, Lyft, Bristol-Myers, PayPal - 5 Things You Must Know Thursday

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA Decision On BMYs Drug Postponed, ENTAs PBC Study Fails, MGNX Turns Heads

Todays Daily Dose brings you news about the revised FDA decision date for Bristol Myers CAR T cell therapy for…

UPDATE 1-U.S. FDA extends review of Bristol Myers cancer therapy acquired in Celgene deal

Bristol Myers Squibb Co said on Wednesday the U.S. FDA has decided to extend the approval timeline for the drugmakers experimental blood…

U.S. FDA extends review of Bristol Myers cancer therapy acquired in Celgene deal

Bristol Myers Squibb said on Wednesday the U.S. drug regulator had extended the review of its experimental blood cancer therapy by three…

FDA extends action date for Bristol-Myers liso-cel to November 16

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

2 Best Pharma Stocks to Buy in May

AstraZeneca and Bristol Myers Squibb should both deliver outstandings returns for investors this month and beyond....…

Factors Setting the Tone for Bristol-Myers (BMY) Q1 Earnings

Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports first-quarter 2020…

FDA accepts for priority review Bristol Myers Squibbs application for CC-486 for maintenance treatment of adults in remission with AML

CC-486 is an investigational oral hypomethylating agent, for the maintenance treatment of adult patients with AML, who achieved complete remission…

3 Healthcare Stocks With a Solid Bottom Line -- and a Dividend

Bristol Myers Squibb, Cardinal Health, and McKesson are all underpriced....…

European advisory group backs Bristol-Myers and Accelerons luspatercept

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Stock Moves -0.84%: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $61.11, marking a -0.84% move from the previous day....…

Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth

Bristol-Myers (BMY) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Oregon’s Pension Bet Big on Tesla and GE Stocks. Here’s What It Sold.

The Oregon Public Employees Retirement Fund sold about a sixth of its AT&T investment in the first quarter. OPERF, as…

Why Youre Smart to Buy Bristol Myers Squibb

Pat yourself on the back if youre Investing in this big pharma stock....…

CYCC In STOPCOVID, EXEL Hits New High, NVS Trialing Malaria Drug For COVID-19

Todays Daily Dose brings you news about Bristol-Myers CheckMate -743 study results; Cyclacel Pharmas entry into COVID-19 drug bandwagon; Exelixis…

Bristol Myers Squibbs Cancer Drug Opdivo Successful in 2 Clinical Trials

In combination with other drugs, Opdivo helped patients with kidney cancer and mesothelioma....…

CORRECTED-Bristol Myers says Opdivo performs well in kidney, lung cancer trials

Bristol Myers Squibb Co said on Monday that its blockbuster cancer immunotherapy Opdivo performed well in two separate late-stage trials, prolonging survival in…

Bristol-Myers-Exelixis Kidney-Cancer Drug Meets Key Phase III Endpoint

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb: Fortschritte bei Krebstherapie

Bristol Myers Squibb: Fortschritte bei Krebstherapie...…

Bristol-Myers Squibb: Studienerfolg beim wichtigen Krebsmittel Opdivo - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Bristol-Myers Squibb-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Bristol-Myers…

Celgene-Käufer Bristol-Myers Squibb: Das ist stark - jetzt einsteigen-

Der US-Konzern Bristol-Myers Squibb hat in den USA mit seinem wichtigen Krebsmittel Opdivo einen Studienerfolg erzielt. Das Unternehmen hat sich…

Bristol-Myers Squibb erreicht mit Krebs-Kombitherapie Phase-III-Studienziele

PRINCETON (dpa-AFX) - Der US-Pharmakonzern Bristol-Myers Squibb hat in den USA mit seinem wichtigen Krebsmittel Opdivo einen Studienerfolg erzielt. Eine…

Bristol-Myers Squibb erreicht mit Krebs-Kombitherapie Phase-III-Studienziele

PRINCETON (dpa-AFX) - Der US-Pharmakonzern Bristol-Myers Squibb hat in den USA mit seinem wichtigen Krebsmittel…

Exelixis, Bristol-Myers stocks get a boost from upbeat trial results of a Kidney cancer treatment

Shares of Exelixis Inc. shot up 8.1%, while Bristil-Myers Squibb Co.'s stock slipped 0.3% in premarket trading Monday,…

Bristol Myers says Opdivo performs well in kidney, lung cancer trials

Bristol Myers Squibb Co said on Monday that its blockbuster cancer immunotherapy Opdivo performed well in two separate late-stage trials, prolonging survival in…